# A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

> **NCT06095128** · PHASE4 · RECRUITING · sponsor: **Takeda** · enrollment: 65 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Vedolizumab
- **DRUG:** Tofacitinib

## Key facts

- **NCT ID:** NCT06095128
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-12
- **Primary completion:** 2027-07-09
- **Final completion:** 2027-07-09
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06095128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06095128, "A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06095128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*